AMN Healthcare Services (AMN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on February 21. Analyst Jeffrey Silber from BMO Capital maintained a Buy rating on the stock and has a $33.00 price target.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Jeffrey Silber’s rating is based on a combination of factors pointing to a potential turnaround for AMN Healthcare Services. Despite a decline in business from the pandemic peak, Silber believes the company is nearing the end of its downturn. The latest quarter results were better than expected primarily due to a significant boost from labor disruption revenues, which exceeded guidance substantially. Additionally, the Nurse and Allied Solutions segment showed sequential growth for the first time in three years, indicating a return to more stable conditions as 2025 approaches.
Although the guidance for the first quarter of 2025 is mixed, with revenues slightly above consensus but margins a bit below, Silber sees positive signs. The Physician and Leadership Solutions segment reported revenue growth in line with expectations, and Technology and Workforce Solutions outperformed its guidance. These developments, along with management’s outlook for more ‘normalcy’ in the business environment, contribute to Silber’s Buy rating on the stock, suggesting confidence in AMN’s ability to navigate the current challenges and improve performance moving forward.
In another report released today, JMP Securities also maintained a Buy rating on the stock with a $33.00 price target.